Growth Metrics

Biomerica (BMRA) Cash from Financing Activities (2016 - 2026)

Biomerica's Cash from Financing Activities history spans 16 years, with the latest figure at $61000.0 for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 96.49% to $61000.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $1.5 million, a 84.4% decrease, with the full-year FY2025 number at $2.1 million, up 2706.17% from a year prior.
  • Cash from Financing Activities hit $61000.0 in Q1 2026 for Biomerica, down from $482000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for BMRA hit a ceiling of $7.4 million in Q2 2023 and a floor of -$5000.0 in Q2 2025.
  • Historically, Cash from Financing Activities has averaged $1.2 million across 4 years, with a median of $482000.0 in 2025.
  • Biggest five-year swings in Cash from Financing Activities: soared 19414.14% in 2023 and later plummeted 96.49% in 2026.
  • Tracing BMRA's Cash from Financing Activities over 4 years: stood at $237000.0 in 2022, then soared by 3001.27% to $7.4 million in 2023, then crashed by 93.44% to $482000.0 in 2025, then crashed by 87.34% to $61000.0 in 2026.
  • Business Quant data shows Cash from Financing Activities for BMRA at $61000.0 in Q1 2026, $482000.0 in Q4 2025, and $920000.0 in Q3 2025.